BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23541273)

  • 1. Viral-associated lymphoid proliferations.
    Pittaluga S
    Semin Diagn Pathol; 2013 May; 30(2):130-6. PubMed ID: 23537914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-neoplastic B-cell predominant lymphoid proliferations at the organs exposed to external environment mimicking lymphoma: A potential diagnostic pitfall.
    Fan Y; Thong BKS; Binshen O; Shen X; Yi H; Wang C
    Int J Immunopathol Pharmacol; 2024; 38():3946320241264369. PubMed ID: 38886178
    [No Abstract]   [Full Text] [Related]  

  • 3. Top Ten Lymphoproliferative Lesions Not to Miss When Evaluating Oral Ulcer Biopsies.
    Hyrcza MD; Lindenmuth TR; Auerbach A
    Head Neck Pathol; 2023 Mar; 17(1):99-118. PubMed ID: 36928739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias.
    Ward JM; Rehg JE; Morse HC
    Toxicol Pathol; 2012 Apr; 40(3):425-34. PubMed ID: 22215512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Florid follicular lymphoid hyperplasia of the palate: review of the literature and report of an illustrative case.
    Brooks JK; Alajaji S; Sultan AS; Parraguirre YE; Cerrito JF; Gupta R; Price JB; Lubek JE; Younis RH
    Quintessence Int; 2024 May; 0(0):0. PubMed ID: 38726762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical lymphoid proliferations: the pathologist's viewpoint.
    Hussein MR
    Expert Rev Hematol; 2013 Apr; 6(2):139-53. PubMed ID: 23547864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early lymphoid lesions: conceptual, diagnostic and clinical challenges.
    Ganapathi KA; Pittaluga S; Odejide OO; Freedman AS; Jaffe ES
    Haematologica; 2014 Sep; 99(9):1421-32. PubMed ID: 25176983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.
    Fend F; Cabecadas J; Gaulard P; Jaffe ES; Kluin P; Kuzu I; Peterson L; Wotherspoon A; Sundström C
    J Hematop; 2012 Sep; 5(3):. PubMed ID: 24307917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder.
    Szablewski V; René C; Costes V
    Virchows Arch; 2015 Oct; ():. PubMed ID: 26493984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic criteria for distinguishing between benign and malignant extranodal lymphoid infiltrates.
    Burke JS
    Semin Diagn Pathol; 1985 Aug; 2(3):152-62. PubMed ID: 3916552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologic evaluation of lymphoproliferative lesions of the orbit/ocular adnexa: an analysis of 46 cases.
    Laucirica R; Font RL
    Diagn Cytopathol; 1996 Sep; 15(3):241-5. PubMed ID: 8955609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early neoplastic lymphoid lesions.
    Carvajal-Cuenca A; Campo E
    Semin Diagn Pathol; 2013 May; 30(2):146-55. PubMed ID: 23541273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis.
    Burke JS
    Arch Pathol Lab Med; 2011 Oct; 135(10):1283-97. PubMed ID: 21970484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Florid reactive lymphoid hyperplasia of the lower female genital tract (lymphoma-like lesion): a benign condition that frequently harbors clonal immunoglobulin heavy chain gene rearrangements.
    Geyer JT; Ferry JA; Harris NL; Young RH; Longtine JA; Zukerberg LR
    Am J Surg Pathol; 2010 Feb; 34(2):161-8. PubMed ID: 20087162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.